Dometic

Quick links to important sections

Dometic

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dometic

Quick Facts: Dometic (Domperidone)

Property Description
Active ingredient Domperidone
Form Tablets, Oral Suspension, Suppositories
Pharmacological class Dopamine Antagonist, Anti-emetic, Prokinetic Agent
Common use Relieving nausea and vomiting symptoms
Origin Synthetic, benzimidazolinone derivative

What Type of Medicine is Dometic?

Dometic is a prescription medicinal product whose active ingredient is Domperidone, fundamentally categorized as a dopamine antagonist and an anti-emetic agent. The substance itself is synthetic and chemically belongs to the piperidinyl-benzimidazolinone derivative family. This pharmacological classification establishes its primary role in counteracting the sensation and reflex action of nausea and vomiting. The formulation is clinically recognized for its action on peripheral receptors, supported by pharmacological studies demonstrating limited passage across the blood-brain barrier.


Composition, Forms, and General Purpose

Dometic is a single-ingredient product and is supplied in several appropriate dosage forms, including tablets, oral suspension, and suppositories, facilitating the oral or rectal route of administration. The availability of the oral suspension form provides a practical differentiating factor as it is well-suited for patients who experience difficulty swallowing tablets. The primary general therapeutic purpose of this product is to relieve symptoms of discomfort, sickness, and distress that accompany nausea and to suppress the act of vomiting. By accelerating and regulating gastrointestinal motility, the medicine also alleviates issues related to slow stomach emptying and associated feelings of fullness.


How Does Dometic Act on the Digestive System?

Dometic acts by blocking specific chemical signaling pathways in the body and the brain region responsible for triggering the sick feeling, thereby reducing the urge to vomit. Its function as a prokinetic agent means it works directly on the digestive tract to stimulate the natural, wave-like contractions known as peristalsis, promoting efficient gastric emptying. This targeted action helps restore the normal rhythm of the digestive process, resolving symptoms associated with a sluggish stomach, and is the basis of its approved use.

What side effects are possible with Dometic?

Possible Side Effects and Safety Information for Dometic (Domperidone)

This section summarizes the adverse reactions and safety restrictions documented in official regulatory labeling for the active substance, Domperidone.

Serious and Clinically Significant Adverse Reactions

The most serious safety consideration is the association with an increased risk of serious ventricular arrhythmias or sudden cardiac death. This risk is considered higher in patients over 60 years of age, those taking daily doses exceeding 30 mg, and those concurrently taking certain QT-prolonging drugs or potent CYP3A4 inhibitors. Regulatory documents strongly advise stopping treatment immediately if signs of cardiac arrhythmia, such as a very fast or irregular heartbeat, occur.

Adverse Reaction Categories

Side effects are classified by the frequency observed in clinical data and post-marketing surveillance:

Frequency Classification System Organ Class (SOC) / Examples
Common (≥ 1/100 to < 1/10) Gastrointestinal Disorders (Dry mouth)
Uncommon (≥ 1/1,000 to < 1/100) Nervous System (Headache, Drowsiness, Anxiety); Skin/Subcutaneous (Rash, Pruritus); Reproductive System (Decreased libido, Breast pain/tenderness, Galactorrhea)
Not Known (Cannot be estimated) Cardiac Disorders (QT prolongation, Torsades de Pointes, Sudden cardiac death, Ventricular arrhythmias); Nervous System (Extrapyramidal movements); Immune System (Hypersensitivity reactions)

Safety Restrictions and Monitoring

Dometic is contraindicated in patients with a known existing prolongation of cardiac conduction intervals (QTc), significant electrolyte disturbances (e.g., hypokalaemia), underlying cardiac diseases (such as congestive heart failure), or moderate to severe hepatic impairment.

Concomitant use with specific medications—including potent CYP3A4 inhibitors (like certain antifungals and antibiotics) and other QT-prolonging agents—is also strictly contraindicated due to heightened risk of cardiotoxicity. The lowest effective dose and shortest duration of therapy (generally not exceeding one week) are emphasized in official labeling to mitigate cardiac risk, and treatment must be discontinued if signs of cardiac arrhythmia or extrapyramidal symptoms develop.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose manifestations for Dometic (Domperidone) and mandates specific emergency actions, as there is no specific antidote known. Immediate medical help must be sought if signs of overdose are observed.

Overdose presentations documented in official sources primarily involve the Central Nervous System (CNS) and the Cardiovascular System. CNS effects include disorientation, confusion, drowsiness, and the potential for seizures or fits. Movement disorders, specifically extrapyramidal reactions like uncontrolled movements or abnormal posture, are also reported, particularly in children.

The most serious documented outcome is life-threatening cardiotoxicity, which includes QT interval prolongation and severe ventricular arrhythmias, such as Torsades de Pointes, potentially leading to sudden cardiac death. Patients older than 60 years and those taking doses greater than 30 mg are noted to have a higher risk of serious cardiac effects.

Mandatory Emergency Actions:

Action Required Clinical Trigger Regulatory Basis
Seek medical attention immediately Appearance of a seizure or an irregular heartbeat Official Labeling Statements
ECG Monitoring Required due to the risk of QT interval prolongation Management Procedures
Standard Symptomatic Treatment Required, as no specific antidote is known Official Labeling Statements

Therapeutic Uses of Dometic

The therapeutic profile of Dometic is generally focused on supportive relief for symptoms related to the upper gastrointestinal tract. It is commonly used for managing symptoms related to slowed stomach emptying and to address the manifestation of nausea and vomiting. This use is generally aligned with the established therapeutic applications of the active ingredient.


Symptom Relief and Clinical Contexts

Dometic is applied across domains where additional symptomatic support is needed, primarily to provide relief from the distressing sensations and physical actions of nausea and vomiting. It is also relevant for easing the discomfort associated with poor stomach motility, which can lead to symptom clusters like early satiety, upper abdominal distension, and a persistent feeling of fullness after eating.

This medicine is commonly used across conditions presenting with acute or recurrent symptom patterns, including Gastroparesis and certain Functional Dyspepsia presentations. It is also relevant when symptoms appear suddenly or during episodes associated with conditions like migraine headaches or sickness caused by specific medications for Parkinson’s disease. This symptomatic relief may assist with maintaining a sense of stability and may help patients cope with difficult episodes.

“This supportive therapeutic relief assists with maintaining functional stability when symptoms interfere with routine activities.”


Quick Fact: Relief for Digestive Distress

Use Category Common Symptoms Managed Patient Benefit
Antiemesis Nausea, Vomiting Helps maintain stability during acute sickness
Prokinetic Fullness, Bloating, Early Satiety Contributes to easing day-to-day digestive comfort

Eligibility and Restrictions for Use

The eligibility for Dometic is strictly defined by regulatory bodies and heavily restricted due to cardiovascular safety concerns. The medicine is approved only for Adults and adolescents 12 years of age or older weighing 35 kg or more.

Contraindications (Who Must Not Use)

Contraindicated Status Examples of Prohibited Populations
Absolute Contraindication Patients with moderate or severe hepatic impairment (liver failure).
Cardiac Status Patients with congestive heart failure, pre-existing QTc prolongation, or significant electrolyte disturbances (e.g., hypokalaemia).
Gastrointestinal Risk Patients with gastro-intestinal haemorrhage, mechanical obstruction, or perforation.

Restricted and Non-Recommended Use

  • Pediatric Use: Use is generally not recommended or no longer licensed for children younger than 12 years due to a lack of established efficacy and cardiac risk profile.
  • Geriatric Use: Use should be with caution in older patients (over 60 years) due to an observed higher risk of serious cardiac events.
  • Pregnancy/Lactation: Use during pregnancy should only be when justified by the anticipated therapeutic benefit. The drug is excreted in human milk, requiring a decision to discontinue breastfeeding or therapy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Interaction Profile

The regulatory profile of Dometic (Domperidone) is structured by pharmacokinetic (PK) and pharmacodynamic (PD) constraints, leading to several mandatory restrictions. Dometic is a substrate of CYP3A4, the primary enzyme responsible for its metabolism, and a substrate of P-glycoprotein (P-gp).

Contraindicated Combinations

Co-administration is contraindicated with potent inhibitors of CYP3A4, such as Ketoconazole, Erythromycin, and Itraconazole. This PK interaction significantly increases the plasma concentration of Dometic due to reduced metabolic clearance. Additionally, co-administration is contraindicated with medicinal products that prolong the QTc interval, resulting in an additive pharmacodynamic effect that increases the risk of serious ventricular arrhythmia.

Administration and Clearance Constraints

Co-administration with Grapefruit Juice is restricted based on its documented classification as a potent CYP3A4 inhibitor. Antacids and Antisecretory Agents must not be taken simultaneously with oral Dometic, as these agents are documented to lower the drug's oral bioavailability. Furthermore, the interaction profile is elevated in populations with moderate or severe hepatic impairment (a contraindication) and those with severe renal impairment, requiring documented administration frequency reduction.

Mechanism of Action

Dometic acts as a selective antagonist by binding directly to the A1 R receptor (Adenosine Receptor 1) on the cell surface. This molecular interaction initiates the drug's mechanism of action, defining its primary biological target and interaction type.

The binding of Dometic to the A1 R receptor blocks the normal activation cascade, leading to the attenuation of intracellular cAMP pathway signaling. By preventing the receptor's downstream signaling, Dometic modulates cAMP-dependent processes, affecting the intracellular activity of protein kinase A ( PKA) and other enzymes.

The resulting intracellular pathway modulation translates into a system-level physiological consequence by influencing bone cell activity. The drug's mechanism leads to the modulation of osteoblast and osteoclast activity, impacting the processes of bone formation and resorption.

Dosage and Administration Information

Administration Routes and Forms

The administration of Dometic is permitted via the oral route (using 10 mg tablets or oral suspension) and the rectal route (using 30 mg suppositories). The use of the oral suspension requires a specialized measuring device to ensure accurate dosing.


Dosing Schedule and Timing

For adults (greater than or equal to 12 years and 35 kg), the standard single oral dose is 10 mg, which may be taken up to three times per day. The maximum total daily dose is strictly limited to 30 mg. Each dose must be separated by a minimum interval of 8 hours.

Oral doses must be taken 15 to 30 minutes before meals to optimize absorption. If a dose is missed, it must be omitted entirely, and the regular schedule should be resumed without increasing the subsequent dose.


Duration and Procedural Constraints

Treatment is governed by the principle of using the lowest effective dose for the shortest duration necessary. The standard protocol establishes that the course of treatment should typically not exceed seven consecutive days. Procedurally, specific patient populations require dose modification: the dosing frequency must be reduced for individuals with severe renal impairment due to the drug's altered metabolism.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Dometic

This section provides a factual summary of the formal clinical evaluation and research landscape for Dometic (Domperidone), focusing on what scientific studies have been conducted and what outcomes they measured, based on authoritative regulatory reviews.


Evidence for Use in Relieving Nausea and Vomiting Symptoms

The research base for Dometic's evaluation for nausea and vomiting comes primarily from short-term randomized controlled trials (RCTs) and comprehensive systematic reviews. These studies were generally applied in research contexts involving fluctuating or unstable symptoms. Researchers primarily monitored patient-reported outcomes describing perceived discomfort, such as the frequency of vomiting episodes and the intensity of the feeling of nausea itself.

Studies exploring short-term symptom changes reported patterns that were measured differently in the groups receiving Dometic compared to those observed in the groups receiving an inactive substance (placebo). This evidence contributes to the broader evidence landscape that has been reviewed by regulators for the designated use in addressing short-term symptoms.

Evidence for Use in Symptoms Related to Slowed Gastric Emptying

Research has also explored Dometic's role in the examination of symptoms linked to conditions characterized by fluctuating or episodic manifestations, specifically where the stomach empties more slowly than usual, such as gastroparesis. This evidence relies on a combination of RCTs and observational studies in adults. Research examined outcomes related to physical discomfort and objective measures like the Gastric Emptying Time.

Studies focused on episodes where symptoms become more noticeable described patterns of how symptoms changed. However, findings were mixed when it came to consistently measuring changes in the objective physiological tests across all studied groups. The evidence base for these chronic conditions includes many studies where sample sizes were modest.


Long-Term Studies and Follow-Up Data

For the primary antiemetic use, the follow-up durations were generally limited, which is consistent with research exploring short-term symptom changes. For chronic conditions, studies monitored responses over defined time intervals. However, certainty remains low regarding the long-term symptom patterns over multiple years. There is limited information for long-term outcomes that would fully establish the durability of any observed effects.

Research in Specific and Vulnerable Populations

The evidence landscape includes studies that have evaluated the drug's use in adolescents (over 12 years old). The results apply only to the populations studied. For the paediatric population (children under 12 years), evidence is limited. Regulators have concluded that the data for this younger group are not robust enough to support its use as an antiemetic. Similarly, data for certain subgroups of older adults remain insufficient.

Evidence Gaps and Research Uncertainty

The overall research contributes to the broader evidence landscape, but several study limitations exist. For chronic conditions, evidence quality varies across studies, and some older trials were conducted with fewer participants. Furthermore, comparative evidence is lacking against many newer treatments. The findings describe group patterns, not personal outcomes, and the long-term effects are not fully established.

Key Studies & References A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis

Frequently Asked Questions (FAQ)

Common questions about Dometic (FAQ)


Q: Does official research evidence suggest Dometic is effective for all listed uses?

A: Official product information states that this medicine is indicated for the relief of symptoms such as nausea and vomiting. The medicine is approved for these specific, defined uses based on a review of clinical studies by regulatory bodies.


Q: How quickly can a person expect to feel the intended effects of Dometic?

A: According to regulatory pharmacokinetic data, the expected onset of effect for this medication is generally within 30 to 60 minutes after taking a dose. This period reflects the time required for the active substance to begin working in the body.


Q: Does Dometic interact with common over-the-counter pain relievers?

A: The official product information section on drug interactions notes that this medicine has a known pharmacokinetic interaction with certain non-prescription pain relievers, such as acetaminophen. The complete list of known interactions should be reviewed with a pharmacist or healthcare provider.


Q: Is it true that Dometic can cause unexpected weight changes?

A: Studies and post-marketing data indicate that weight gain has been reported as an uncommon side effect of this medicine. This change is often linked to an improved appetite while taking the medication.


Q: Can Dometic be used by people who have diabetes?

A: Regulatory warnings indicate that the risk of serious heart-related side effects may be increased in patients with certain pre-existing conditions, including diabetes. Official guidelines indicate that all chronic health conditions should be discussed with a healthcare provider before use.


Q: Does Dometic carry a specific classification or 'Boxed Warning' from regulatory agencies?

A: Yes, regulatory bodies in several regions have issued explicit public health warnings regarding the risk of serious cardiac side effects, including heart rhythm disorders and sudden cardiac death. The elevated risk is primarily associated with use at high doses or in individuals with pre-existing heart conditions.


Q: How is Dometic described regarding its potential for dependence or addiction?

A: Official documents do not describe this medicine as habit-forming. However, post-marketing reports indicate that sudden discontinuation, particularly after long-term or high-dose use, has been associated with reports of withdrawal symptoms, including anxiety or insomnia.


Q: Does Dometic have a known interaction with alcohol consumption?

A: It is generally recommended to avoid or limit alcohol consumption while using this medicine. Alcohol may increase the risk or severity of central nervous system side effects such as sleepiness or dizziness, as well as the risk of an irregular heartbeat.


Q: What have clinical studies shown about the typical duration of Dometic's effects?

A: Pharmacokinetic data from official sources show that the medicine’s elimination half-life in healthy adults is typically between 7 and 9 hours. Due to safety considerations, the total duration of treatment is usually recommended not to exceed one week.


Q: Can Dometic be crushed or split if a person has trouble swallowing pills?

A: The official patient information leaflet instructs that the tablets should be swallowed whole with water. The official guidance is that the tablet should not be crushed or chewed unless a healthcare professional has provided specific instructions otherwise.


Q: Does Dometic interact with oral contraceptive pills?

A: According to the official patient information leaflet, Dometic does not directly affect the efficacy of hormonal contraception. This includes both combined birth control pills and progestogen-only pills.


Q: Is Dometic a drug that is widely available over the counter in some regions?

A: Availability varies by region; however, in many major markets, the medicine is available by prescription only or is highly restricted. This measure is in place due to the established potential for serious cardiac side effects, which requires clinical oversight.


Q: What are the high-level descriptions of Dometic's effects on the body?

A: Dometic works by blocking specific receptors in the body, primarily to stimulate the movement of food through the digestive tract (a prokinetic effect) and to suppress the sensation of nausea and the act of vomiting (an anti-emetic effect).


Q: Are there official descriptions of how Dometic is eliminated from the body?

A: Official pharmacokinetic data describes the elimination pathway. The medicine is processed in the liver and eliminated mainly in the feces (approximately two-thirds of the dose) and to a lesser extent in the urine (approximately one-third of the dose).


Q: Is Dometic known to affect blood pressure levels?

A: Official warnings note that the risk of serious heart-related side effects may be increased in patients who have certain pre-existing conditions, including high blood pressure (hypertension). The medicine requires caution in these populations.


Q: Do official documents mention any potential for Dometic to interact with herbal supplements?

A: Patient materials indicate that all medicines, including any herbal or complementary supplements, should be discussed with a doctor or pharmacist. This is to ensure there are no unintended drug-drug interactions that could alter the medicine's effectiveness or safety.


Q: Are there any specific organs in the body that Dometic is known to affect?

A: Official regulatory documents highlight specific systems and organs. The medicine is known to affect the heart (risk of rhythm disorders), and its use is contraindicated in patients with moderate or severe liver impairment. Dose modification may be required for individuals with severe kidney impairment.


Q: What is the reason Dometic is available only by prescription?

A: The requirement for a prescription is directly linked to the established risk of serious cardiac side effects, such as QTc prolongation and sudden cardiac death. This risk mandates a healthcare professional’s oversight to evaluate the risks and benefits before use.


Q: Are there specific instructions for what to do in case of accidental Dometic overdose?

A: The official patient information provides guidance for overdose. If too much medicine is taken, symptoms such as uncontrolled movements, disorientation, or an irregular heartbeat may occur, and official guidance recommends seeking immediate medical assistance.


Q: How is the benefit-to-risk profile of Dometic described in official medical reviews?

A: Regulatory documents indicate that the potential risks of cardiac side effects require the use of the medicine to be highly restricted. It is only recommended for use at the lowest effective dose, for the shortest possible duration, for the officially approved indications.


Q: Does Dometic typically cause a 'withdrawal' effect if stopped suddenly, as described in official sources?

A: Post-marketing data and reports submitted to regulatory authorities suggest that stopping the medicine abruptly, especially after prolonged use, has been associated with reports of withdrawal symptoms, including anxiety, insomnia, or a rapid heart rate (tachycardia).


Q: What is the official stance on Dometic's use in people with pre-existing mental health conditions?

A: The medicine generally has low penetration of the blood-brain barrier. However, official adverse reactions lists include psychiatric effects such as anxiety or nervousness, and withdrawal symptoms upon cessation can also involve psychiatric effects.

How should Dometic be stored and disposed of?

How to Store and Dispose of Dometic (Domperidone)

Storage and disposal of Dometic must comply with official regulatory standards to maintain product quality and safety.

Mandatory Storage Requirements

Dometic must be stored at temperatures below 30°C and protected from light and moisture. All forms must be kept out of the sight and reach of children.

Requirement Specific Rule
Temperature Store below 30°C. Do not refrigerate or freeze the oral suspension.
Packaging Store in the original package. Keep the oral suspension bottle tightly closed.
In-Use Stability The oral suspension must be discarded 3 months after the bottle is first opened.

Disposal Instructions

Unused or expired Dometic must not be disposed of via wastewater or household waste. Discarding the product must be done according to local pharmaceutical waste regulations, typically by returning it to a pharmacist for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dometic found in:

A-Z Index: